South Korea Sclerotherapy Market Size, Share, and COVID-19 Impact Analysis, By Agents (Detergents, Chemical Irritants, and Osmotic Agents), By Type (Ultrasound Sclerotherapy, Liquid Sclerotherapy, and Foam Sclerotherapy), and South Korea Sclerotherapy Market Insights, Industry Trend, Forecasts to 2035

  South Korea Sclerotherapy Market Insights Forecasts to 2035

• The South Korea Sclerotherapy Market Size Was Estimated at USD 24.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.66% from 2025 to 2035
• The South Korea Sclerotherapy Market Size is Expected to Reach USD 45.1 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Sclerotherapy Market Size is anticipated to reach USD 45.1Million by 2035, Growing at a CAGR of 5.66% from 2025 to 2035. The market is driven by the rising incidence of venous illnesses that impact a large percentage of the population, such as varicose veins and chronic venous insufficiency. Patients look for minimally invasive, efficient treatments that improve their looks and manage medical issues.

Market Overview

The economic activity related to the medical process used to treat varicose veins, spider veins, and other venous problems is included in the sclerotherapy market. This covers the creation, production, and distribution of sclerosing agents in addition to the medical professionals' delivery of sclerotherapy services. The rising incidence of venous disorders, the expanding need for less invasive treatment alternatives, and developments in sclerotherapy methods and equipment are the main factors propelling the market. Better Look: Both spider and varicose veins can be efficiently reduced in appearance with sclerosing, resulting in skin that is smoother and more evenly toned. By treating the underlying venous problems, it can reduce varicose vein pain, aching, and discomfort. Sclerosing is the main treatment for many disorders, the market is expected to grow as more people become afflicted. Because sclerotherapy is less invasive than surgery, people who want shorter recovery times and lower risks find it more tempting. Effective treatments like sclerotherapy are becoming more and more necessary as conditions like varicose veins and spider veins become increasingly prevalent.

Report Coverage

This research report categorizes the market for South Korea sclerotherapy market based on various segments and regions forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea sclerotherapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea sclerotherapy market.

Driving Factors

The rising prevalence of varicose and spider veins, largely due to aging populations, sedentary lifestyles, and obesity. Growing demand for minimally invasive procedures has increased the adoption of sclerotherapy, which offers quicker recovery and fewer complications than surgery. Technological advancements, such as ultrasound-guided and foam-based sclerotherapy, have improved treatment efficacy and safety.

Restraining Factors

Limited awareness about the procedure in developing regions hampers adoption. Additionally, the availability of alternative treatments like laser therapy or surgery may reduce demand. High costs of advanced sclerosing agents and lack of insurance coverage in some countries also restrict patient access, slowing overall market growth despite increasing vein-related conditions.                

Market Segmentation

The South Korea sclerotherapy market share is classified into agents and type.

• The detergents segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea sclerotherapy market is segmented by agents into detergents, chemical irritants, osmotic agents. Among these, the detergents segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The safety record shown effectiveness as sclerosing agents. It is often known that detergents can successfully irritate the vein wall, resulting in the closure of varicose veins and other venous disorders. Their reputation among medical professionals is further increased by the FDA's approval, which promotes broad clinical practice adoption. Additionally, both patients and professionals like detergent sclerotherapy because to its minimal risk of adverse reactions.

• The ultrasound sclerotherapy segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea sclerotherapy market is segmented by type into ultrasound sclerotherapy, liquid sclerotherapy, and foam sclerotherapy. Among these, the ultrasound sclerotherapy segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Developments in imaging technology that improve the accuracy of treatment. Practitioners can more precisely target afflicted veins with real-time ultrasound guidance, increasing injection accuracy and therapy success rates overall. The use of ultrasound-guided sclerotherapy is anticipated to grow dramatically as more medical practitioners become aware of these advantages.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea sclerotherapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GC Biopharma
• Yuhan Corporation
• Chong Kun Dang
• Hanmi Pharm
• Lotte Biologics
• GeneMatrix Inc.
• LegoChem Biosciences
• LG Chem Life Sciences
• MEDIPOST
• Genexine
• Helixmith
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea sclerotherapy market based on the below-mentioned segments:

South Korea Sclerotherapy Market, By Agents

• Detergents
• Chemical Irritants
• Osmotic Agents

South Korea Sclerotherapy Market, By Type

• Ultrasound Sclerotherapy
• Liquid Sclerotherapy
• Foam Sclerotherapy